MYM Nutraceuticals appoints Dr. Charith Adkar as its Chief Science Officer effective immediately.
Dr. Adkar has pursued his PhD in Plant Biology and Crop Production from the University of Milano, Italy with specialization in Molecular Plant Pathology. He has secured his postdoctoral studies at Hirosaki University, Japan and Université de Sherbrooke, Canada. His areas of expertise include Plant Science, Biotechnology, Microbiology, Molecular host-pathogen interactions and Bioinformatics. Dr. Adkar will manage MYM’s scientific, research and technological operations. He will work primarily at the Laval and Weedon production facilities. Rob Gietl, CEO of MYM said “Dr. Adkar will be instrumental in leading MYM to be a global innovator in the science and technology of medicinal cannabis. His proven track record and research in plant biology and crop production will ensure that MYM will be on the cutting edge of cannabis plant discovery and research.”